EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis

Anja Steinmaurer iD, Christian Riedl, Theresa König, Giulia Testa, Ulrike Köck, Jan Bauer, Hans Lassmann iD, Romana Höftberger, Thomas Berger, Isabella Wimmer iD, Simon Hametner

Brain Pathology · 2024

DOI: 10.1111/bpa.13240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2024. Verfasst von Anja Steinmaurer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Iron, Multiple Sclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck Healthcare KGaA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of Bruton's tyrosine kinase (BTK) has been shown to play a crucial role in the proinflammatory response of B cells and myeloid cells upon engagement with B cell, Fc, Toll‐like receptor, and distinct chemokine receptors. Previous reports suggest BTK actively contributes to the pathogenesis of multiple sclerosis (MS). The BTK inhibitor Evobrutinib has been shown to reduce the numbers of gadolinium‐enhancing lesions and relapses in relapsing–remitting MS patients. In vitro, BTK inhibition resulted in reduced phagocytic activity and modulated BTK‐dependent inflammatory signaling of microglia and macrophages. Here, we investigated the protein expression of BTK and CD68 as well as iron accumulation in postmortem control ( n = 10) and MS ( n = 23) brain tissue, focusing on microglia and macrophages. MS cases encompassed active, chronic active, and inactive lesions. BTK + and iron + cells positively correlated across all regions of interests and, along with CD68, revealed highest numbers in the center of active and at the rim of chronic active lesions. We then studied the effect of BTK inhibition in the human immortalized microglia‐like HMC3 cell line in vitro. In particular, we loaded HMC3 cells with iron‐dextran and subsequently administered the BTK inhibitor Evobrutinib. Iron treatment alone induced a proinflammatory phenotype and increased the expression of iron importers as well as the intracellular iron storage protein ferritin light chain (FTL). BTK inhibition of iron‐laden cells dampened the expression of microglia‐related inflammatory genes as well as iron‐importers, whereas the iron‐exporter ferroportin was upregulated. Our data suggest that BTK inhibition not only dampens the proinflammatory response but also reduces iron import and storage in activated microglia and macrophages with possible implications on microglial iron accumulation in chronic active lesions in MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseIronMultiple SclerosisHumansMaleFemaleMiddle AgedAdultMyeloid CellsBrainAgedMicrogliaMacrophagesAntigens, CDAntigens, Differentiation, MyelomonocyticPyrimidinesPiperidines

Stichwörter der Autor:innen

Bruton's tyrosine kinaseEvobrutinibmicrogliamultiple sclerosismyeloid cellsneuroinflammation

Substanzen

Agammaglobulinaemia Tyrosine KinaseIronBTK protein, humanAntigens, CDevobrutinibAntigens, Differentiation, MyelomonocyticPyrimidinesPiperidines

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Division of Neurochemistry and Neuropathology, Medical University of Vienna, Vienna, Austria.
  • Department of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Anja Steinmaurer, Hans Lassmann, Isabella Wimmer

Förderung

  • Merck Healthcare KGaA

Zitieren

APA

Steinmaurer, A., Riedl, C., König, T., Testa, G., Köck, U., Bauer, J., Lassmann, H., Höftberger, R., Berger, T., Wimmer, I., & Hametner, S. (2024). The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis. Brain Pathology. https://doi.org/10.1111/bpa.13240

Vancouver

Steinmaurer A, Riedl C, König T, Testa G, Köck U, Bauer J, et al. The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis. Brain Pathology. 2024. doi:10.1111/bpa.13240

BibTeX
@article{Steinmaurer2024,
  author = {Steinmaurer, Anja and Riedl, Christian and König, Theresa and Testa, Giulia and Köck, Ulrike and Bauer, Jan and Lassmann, Hans and Höftberger, Romana and Berger, Thomas and Wimmer, Isabella and Hametner, Simon},
  title = {The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis},
  journal = {Brain Pathology},
  year = {2024},
  doi = {10.1111/bpa.13240}
}
Kostenlos starten →